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The control of cerebral blood ﬂow is complex, and only beginning to be elucidated. Studies have identiﬁed three key regulatory
paradigms. The ﬁrst is cerebral pressure autoregulation, which maintains a constant ﬂow in the face of changing cerebral perfusion
pressure. Flow-metabolism coupling refers to the brains ability to vary blood ﬂow to match metabolic activity. An extensive
arborization of perivascular nerves also serves to modulate cerebral blood ﬂow, so-called neurogenic regulation. Central to these
three paradigms are two cell types: endothelium and astrocytes. The endothelium produces several vasoactive factors that are
germane to the regulation of cerebral blood ﬂow: nitric oxide, endothelium-dependent hyperpolarization factor, the eicosanoids,
and the endothelins. Astrocytic foot processes directly abut the blood vessels, and play a key role in regulation of cerebral blood
ﬂow. Lastly, new research has been investigating cell-cell communication at the microvascular level. Several lines of evidence point
to the ability of the larger proximal vessels to coordinate vasomotor responses downstream.
1.Introduction
Regulation of blood ﬂow in the human brain is exceed-
ingly complex. There exist multiple overlapping regulatory
paradigms and key structural components. The interaction
of these components, as well as the components themselves,
arenotfullyunderstood.Nonetheless,agreatdealofprogress
has been made in this important ﬁeld.
This paper will discuss the three main regulatory para-
digms involved in the regulation of cerebral blood ﬂow: cere-
bral autoregulation, ﬂow-metabolism coupling, and neuro-
genic regulation. In addition, there are two cell types that
have repeatedly been shown to play a central role in the regu-
lation of cerebral blood ﬂow: endothelial cells and astrocytes.
Lastly,theroleofmicrovascularcommunicationisdiscussed.
2. Cerebral Pressure Autoregulation
The process whereby the cerebral arteries (speciﬁcally arte-
rioles) maintain a constant blood ﬂow (CBF) in the face of
changing cerebral perfusion pressure (CPP) is referred to as
cerebral pressure autoregulation. As shown below in Figure 1,
between CPP pressures of 50–150mm Hg CBF is relatively
constant; above and below these values, however, CBF varies
markedly with CPP.
We view this phenomenon as independent of metabolic
factors,thusthissectionislimitedtochangesinvasculartone
asaresultofCPPonly.Flow-metabolismcouplingisadistinct
phenomenon that will be discussed in the following section.
The exact mechanism underlying cerebral pressure au-
toregulation continues to elude us. Several theories have
beenadvanced,focusingontheendothelium,nerves,andthe
vascularsmooth muscleitself.Becauseoftheextensive inves-
tigation into the perivascular nerve ﬁbers, discussion of this
is relegated to a separate section below.
The endothelium is a dynamic source of a plethora of
vasomodulatorymolecules.Inaddition,ithasbeenproposed
that the endothelium has mechanoreceptor properties that
allow it to contribute to cerebral autoregulation. The two
main mechanical mechanisms that have been evaluated are
shear stress and transmural pressure. Increased ﬂow-velocity
(shear stress) has been shown to induce vasoconstriction
independent of transmural pressure [1]. This response
is attenuated in blood vessels denuded of endothelium.2 International Journal of Vascular Medicine
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Figure 1: Idealized curve demonstrating cerebral pressure autoreg-
ulation.
A similar endothelium-dependent response to increases in
transmural pressure has also been demonstrated. Harder
reproduced this work and also found that arterial constric-
tion was associated with smooth muscle depolarization [2].
Lastly, Rubanyi showed that perfusate isolated from arteries
that had been subjected to increased transmural pressure
was capable of inducing vasoconstriction in na¨ ıve vessels,
implying some endothelial-derived factor [3].
Stretch responses have also been theorized to originate
in smooth muscle cells. Originally formulated by Bayliss in
1902 [4], the so-called “myogenic hypothesis” of cerebral
autoregulationfocusesonthemechanoreceptorpropertiesof
smooth muscle cells themselves. The development in 1981
of isolated vessel techniques allowed the mechanisms to
be separated from ﬂow, neural, metabolic, and endothelial
inﬂuences [5, 6]. Recent work has focused on the transduc-
tion mechanisms between myogenic stretch and subsequent
vasoconstriction,particularlytheroleofstretch-activatedion
channels. Since the ﬁrst recordings of mechanosensitive ion
channels in 1988 [7] ,an u m b e ro fi n v e s t i g a t o r sh a v ef o u n d
evidence for these channels in vascular smooth muscle in a
variety of tissues. The electrical properties of these channels
strongly suggest that they are nonselective cation channels
[8, 9]. The resultant membrane depolarization results in
inﬂux of Ca++ through voltage-gated Ca++ channels and
smooth muscle constriction, a response that is abolished in
the presence of inhibitors to voltage-gated Ca++ channels
[10]. It has also recently been shown that not only the
RhoA-Rho Kinase pathway plays a pivotal role in cerebral
artery mechanotransduction, but also the pathway is more
active at progressively higher levels of stretch [11]. Gokina
and colleagues evaluated the eﬀect of Rho kinase inhibition
on pressure autoregulation in cerebral arteries in the rat.
They found that administration of a speciﬁc inhibitor of
Rho kinase (Y-27632) selectively inhibited pressure-induced
rise in intracellular Ca+ as well as the development of myo-
genic tone. Studies have even demonstrated that calcium-
independent mechanisms, so-called calcium sensitization,
may be present as well. This occurs when agonists lead to
muscle contraction without a corresponding rise in intracel-
lular calcium [12].
3.Flow-Metabolism Coupling
For over a century it has been appreciated that cerebral
blood ﬂow varies with cerebral metabolism [13]. This has
most recently been shown with several functional imaging
modalities, such as PET scanning and BOLD fMRI [14]. So-
called ﬂow-metabolism coupling or functional hyperemia is
perhaps the most clinically relevant of the CBF regulation
paradigms, as cerebral tissue is among the least tolerant
of ischemia. Interestingly enough, it has been shown that
the generation of action potentials alone is not necessarily
the main stimulus in ﬂow-metabolism coupling; rather the
interneuron milieu is capable of generating a signiﬁcant
stimulus even if the endpoint is a decrease in the frequency
of action potentials [15, 16].
There are several molecules that investigators have
focused on as possible links between neuronal activity and
the regulation of cerebral blood ﬂow. All are known to
increase with synaptic transmission, either because they are
involved in the process itself (in the case of K+ and H+) or
because they are known metabolites (adenosine).
Potassium and hydrogen ions are produced by synaptic
transmission, and it has been shown that elevation of
these ions stimulates vasodilation [17, 18], thus providing a
possible mechanism for neurovascular coupling. Potassium
channels have been found in vascular smooth muscle and
have been implicated in the eﬀect of both K+ and H+
elevations [19]. In addition, ATP-sensitive K+-channels have
been found in vascular smooth muscle, suggesting a direct
link between neuronal activity and cerebral blood ﬂow [20].
The well-known phenomenon of CO2 reactivity is mediated
through the action of H+ on cerebral arteries, rather than
CO2 itself. The transduction mechanism of H+ into vasod-
ilation remains elusive, although nitric oxide (NO) has been
implicated as the vasodilatory response to hypercapnia and
acidosis is attenuated by NO inhibitors [21, 22].
Metabolites are an attractive option as messengers for
flow-metabolismcoupling,forobviousreasons.Becausehyp-
oxia and hypoglycemia do not aﬀect activity-induced vasod-
ilatations [23], attention has focused on other by-products
of neuronal activity, most notably adenosine. Extracellular
levels of adenosine rise sharply with neuronal activity, and
topical application of adenosine to cerebral microcirculation
causes vasodilation [24]. Furthermore, adenosine has been
shown to be released in response to administration of
glutamate, a major neurotransmitter in cerebral cortex [25].
Iliﬀ et al. [26] showed that selective blockade of adenosine
receptor (speciﬁcally receptor 2A) attenuated the vasodila-
toryresponsetoglutamateadministration.Furthermore,this
blockade had no eﬀecton either resting vessel diameter or on
CO2 reactivity. Thus adenosine appears to play a signiﬁcant
role in glutamate-induced dilation of pial arterioles.
A signiﬁcant body of evidence supports the function of
NO in ﬂow-metabolism coupling [24, 27, 28], although the
exact pathway is not completely clear. A recent study by
Lindauer et al. demonstrated that the vasodilatory response
to whisker deﬂection was blocked by administration of NO
inhibitors. However, the eﬀect was restored by administra-
tion of cyclic guanosine monophosphate (cGMP) or NOInternational Journal of Vascular Medicine 3
donors, suggesting that NO itself is not the relevant mediator
[29].IthasbeentheorizedthatNOactsasapermissiveagent,
supplying a basal amount of cGMP for other mediators (like
adenosine) to utilize as second messengers [26].
4. Neurogenic Regulation of Cerebral Blood
Flow(Box1inFigure2)
A wealth of functional and histological evidence supports
the existence of an extensive arborization of perivascular
nerves that play a role in regulation of cerebral blood ﬂow.
The functional unit of endothelial cells, perivascular nerves,
and astrocytes has been increasingly recognized as a complex
network that can be considered as a single entity rather than
separate subunits. Referred to as the neurovascular unit, this
characterization has led to investigation into supporting the
unit as a whole, rather than simply focusing on one aspect
[30]. These nerves have diverse origins and neurotransmit-
ters and can be broadly categorized into two categories:
extrinsic and intrinsic.
Extrinsic perivascular innervation refers to vessel inner-
vation outside of the brain parenchyma. Three main sources
of extrinsic perivascular innervation have been identiﬁed:
the trigeminal ganglion, the superior cervical ganglion, and
the sphenopalatine ganglion. These ganglions carry sensory,
sympathetic, and parasympathetic nerves, respectively. It has
been hypothesized that the main role of the sympathetic
n e r v o u ss y s t e mi st oo ﬀer an increased tone to maintain
blood pressure below the upper limit of the autoregulatory
mechanism [31, 32]. Thus pressures that would normally
overwhelm autoregulation are well tolerated. The parasym-
pathetic system is felt to play a role primarily in pathological
states. Because of the central role the trigeminovascular sys-
tem plays in pain sensation, it became an early focus for
migraine. It was later discovered that calcitonin gene-related
peptide (CGRP), a potent vasodilator, is released from
trigeminalnerves[33]. Itwasthustheorizedthatthetrigem-
inovascular system plays a role in counteracting vasocon-
strictive inﬂuences. In addition, the triptan class of migraine
abortive agents act presynaptically to prevent CGRP release,
thereby preventing vascular engorgement and associated
headache.
As shown in Figure 2, once the blood vessel dives deep
into the parenchyma and leaves the virchow-robin space,
they lose their extrinsic innervation and the intrinsic inner-
vation begins. A new set of nerves takes over, arising both
from distant pathways [34–36] and local interneurons [37].
The majority of these nerves do not abut directly on blood
microvesselsthemselves;rathertheyconnecttoastrocytefoot
processes. Depending on the area stimulated, an increase
or decrease in CBF can be elicited. The nucleus basalis,
locus coeruleus, and raphe nucleus have all been implicated
as a source for innervation of cerebral microvasculature.
At present, it is not entirely clear if these neurons directly
contactthemicrovesselsorifthesignalistransducedthrough
astrocytic foot-processes [38].
In addition to distant subcortical pathways, local inter-
neurons also play a role in the regulation of microvascu-
lar tone. It has recently been shown that stimulation of
GABAnergic interneurons causes vasodilation of regional
microvessels [39]. Furthermore, interneurons also seem to
be necessary to transduce the signal from distant subcortical
regionsdescribedabove.Thissuggestsamechanismforfeed-
forward vasodilation [40].
5.Endothelium(Box 2inFigure2)
The cerebrovascular endothelium plays a central role in the
regulation of cerebral blood ﬂow. Once thought to simply
be an inert antithrombotic barrier, the endothelium is now
a p p r e c i a t e da sad y n a m i co r g a nt h a ta c t sa sap h y s i o l o g i c
bridge between the blood vessel lumen and the surrounding
smooth muscle. At present, this bridge is thought of as
comprising 4 main chemical systems: nitric oxide (NO),
endothelium-derived hyperpolarization factor (EDHF), the
eicosanoids, and the endothelins.
Much of the interest in the endothelium began with the
discovery of nitric oxide (NO) as the endothelium-derived
relaxing factor by Furchgott [41] and Ignarro [42] in 1988.
NO is a diﬀusible second messenger that activates guanylate
cyclase (GC), present in smooth muscle cells. Guanylate cyc-
last in turn synthesizes cGMP which causes smooth muscle
relaxation through protein kinase G (PKG) activation of K+
channels and/or closure of voltage-gated calcium channels.
The enzyme that produces NO, nitric oxide synthase
(NOS) has several isoforms. Endothelial NOS (eNOS) is the
isoform found in the cerebral blood vessels, speciﬁcally the
endothelium [43–45]. Neuronal NOS (nNOS) is the isoform
found in neurons. A third isoform, inducible NOS (iNOS)
has been found in the brain under pathological situations
such as hypertension or exposure to endotoxin [46]. It is not
thought to be active in the brain under normal conditions.
Immunohistochemistry has localized eNOS to the endothe-
lium, yet administration of a NOS inhibitor (L-NMMA) to
denuded arteries produces vasoconstriction [47, 48]. This
providesevidenceforthephysiologicalsigniﬁcanceofnNOS,
although the relative contribution of eNOS versus nNOS to
resting tone of the cerebral vasculature is not known.
Despite the dominance of the NO paradigm in endo-
thelial-dependent vasodilatation, it appears that there is a
second mechanism that also operates in the endothelium to
causevasodilatation.Thisisbasedonobservationsthatwhen
NO- and eicosanoid-based pathways are fully inhibited,
further dilatory capacity remains [49–51]. Similar to the
story of EDRF prior to the discovery of NO, so-called
EDHF represents an as of yet unelucidated pathway that
may be another diﬀusible molecule (the present terminology
of “factor” is misleading based on the present data). This
pathwayischaracterizedbyhyperpolarizationofthevascular
smooth muscle and is inhibited by K+-channel blockers.
Golding et al. deﬁned EDHF as a dilation pathway that
[1] requires endothelium, [2] is distinct from eicosanoid or
NO pathways, [3] dilates via hyperpolarization of vascular
smooth muscle, and [4] involves K+-channel activation [52].
It is known that the EDHF pathway begins with an increase
inendothelialCa+2 storesandendswithadecrease insmooth
muscle Ca+2 stores. How these two events are linked is a
matter of continuing study. At present, there are 4 main4 International Journal of Vascular Medicine
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Figure 2: Comprehensive diagram demonstrating the multiple mechanisms of cerebrovascular control. Modiﬁed from Hamel et al., J AP
with permission.
possibilities: eicosanoids, K+, gap junctions, and hydrogen
peroxide [53].
Theeicosanoidsareagroupofvasoactivechemicalmedi-
ators that are derived from arachidonic acid. Three main
enzymesystemshavebeenidentiﬁed:cyclooxygenase(COX),
lipoxygenase (LOX), and epoxygenase (EPOX). Arachidonic
acid is formed from membrane phospholipids by lipases and
is used as a substrate for the aforementioned enzyme systems
[54].
It should be emphasized that these enzyme systems are
not limited to the endothelium; rather they are active in a
varietyoftissues,notablyplatelets.Furthermore,someprod-
ucts cause vasoconstriction and others cause vasodilatation.
The diﬀerential concentrations of the enzymes and their iso-
forms in diﬀerent locations determines the overall eﬀect on
cerebral blood ﬂow. Although all three enzyme systems have
been investigated extensively in the systemic vasculature,
COX is the best understood in the cerebral vasculature—
at present, the role of the LOX and EPOX systems in
the cerebral vasculature is poorly understood. Three COX
isoforms have been found to exist in the cerebral vasculature
[55–58]. Of the multiple metabolites produced by COX,
the vasodilators prostacyclin (PGI2) and prostaglandin E2
(PGE2) are predominant in normal endothelium [59]. While
important in pathologic conditions, it appears that under
normalphysiologytheCOXsystemislessdominant,withthe
NO and EDHF systems described above being the predom-
inant vasodilatation paradigms [60]. The vasoconstrictive
COX metabolites are presently thought to be most relevant
in pathological situations such as traumatic brain injury and
subarachnoid hemorrhage.
The fourth major chemical system active in the endothe-
lium is that of the endothelins. This system is comprised
of two receptors (ETA and ETB) and three ligands (ET-1,
ET-2, ET-3). The eﬀect of the ligands seems to depend on
the receptor rather than the ligand. ETA receptors are found
predominantly in vascular smooth muscle, are stimulated by
ET-1 and ET-2, and mediate vasoconstriction. ETB recep-
tors are found predominantly within the endothelium, are
stimulated by all three ligands, and mediate vasodilatation
[61,62].Ofthethreeligands,ET-1appearstoplaythebiggest
role in the regulation of cerebral blood ﬂow. It can either
be produced via cleavage of proendothelin, or “big ET-1”, or
produced de novo from mRNA in cerebrovascular endothe-
lial cells [63]. In the presence of an intact endothelium, ET-1
bindstoETB andcausesvasodilation[64];invesselsdenuded
ofendothelium,ET-1bindstoETA andcausesvascoconstric-
tion [65, 66]. The picture is somewhat complicated by the
fact that ETA receptors may be found in the endothelium
[67]a n dE T B receptors may be found in smooth muscle [68,
69]. The vasodilatory action of ETB r e c e p t o r si sm e d i a t e d
by NO [70]. Interestingly, there is evidence of a balancing
paradigm between the constricting actions of ET-1 and NO-
mediated vasodilation. ET-1 secretion has been shown to beInternational Journal of Vascular Medicine 5
stimulated by several molecules known to be connected with
NO-induced vasodilation. However, topical administration
of ET receptor blockers does not result in an increase in CBF.
Furthermore, the long lasting eﬀects of the endothelins make
them poorly suited for the minute to minute regulation of
CBF. It is presently thought that endothelins do not contrib-
ute in a major way to resting CBF under normal physiologic
conditions, although they have been shown to play a major
role in several pathological conditions, most notably cerebral
ischemia and cerebral vasospasm [71].
6.Astrocytes(Box3in Figure2)
Astrocytes are in a unique anatomical position to eﬀect
CBF; their processes extensively ensheath brain capillaries
[38],therebyphysicallylinkingthecerebralmicrovasculature
with synapses. Their primary role was originally thought to
involve extracellular K+ buﬀering. More recently, in vitro
studies have shown astrocytes to be capable of cell-to-cell
communication through gap junctions, suggesting a possible
role for modulation of neuronal and vascular function.
Early work on the mechanism of astrocytic involvement
of cerebral blood ﬂow regulation focused on potassium.
Astrocytes were known to uptake excess extracellular potas-
sium, and Newman et al. showed that the ions were then
shunted to the endfeet processes [72]. Given the location of
astrocytic foot processes on the cerebral vasculature and the
vasodilatory eﬀects of K+, it was theorized that this was a
mechanism whereby neuronal activity was linked to cerebral
vasodilation. Subsequent work by Paulson showed that this
theory ﬁts the temporal relationship of K+ increases to
vasodilation better than alternative theories involving simple
potassium diﬀusion [18].
Work by Zonta et al. using brain slice preparations
found that electrical stimulation of astrocytes resulted in an
increase in intracellular Ca++ followed by vasodilation of
arterioles contacted by foot processes of that astrocyte [73].
This response was mimicked by administration of glutamate
agonists and attenuated by administration of glutamate
antagonists. Astrocytes are known to express a subtype of
glutamate receptor that results in an increase in intracellular
Ca++, thus it was inferred that astrocytic foot processes
sensed the synaptic activity and then responded to that
activity by inducing vasodilation of the appropriate blood
vessels [26].
7. MicrovascularCommunication
(Box4inFigure2)
Much current interest is focused on the role microvascular
b e di nt h er e g u l a t i o no fc e r e b r a lb l o o dﬂ o w .S p e c i ﬁ c a l l y ,
there is evidence that communication within the blood ves-
sels themselves at the microvascular level plays a key role in
the overall regulation of blood ﬂow in the brain. Since there
is a substantial increase in resistance at the arteriole level, the
proximal vessels must coordinate with the microvasculature
in order to ensure adequate microperfusion. Several lines of
evidence have been presented proving that this occurs.
Rosenblum et al. ﬁrst presented in vivo evidence for
the presence of coordinated vasomotor responses (CVR) in
mouse pial arterioles [74], by demonstrating that the local
constriction response initiated by micropipette application
of uridine triphosphate could travel for 300µmo rm o r e
upstream from the point of application. Moreover, conduc-
tion could be interrupted by local vascular wall injury (light-
dye technique). Subsequently, Dietrich et al. [75]d e s c r i b e d
conducted vasodilation in penetrating arterioles isolated
from the rat brain to various vasoactive agents, including ad-
enosine and ATP. They also suggested that endothelial cells
appeared to play a key role in the conducted responses of
intracerebral arterioles to potassium [76] .T h es a m eg r o u p
[77] also found attenuation of conducted vasodilation by
oxyhemoglobin treatment, suggesting a role by vascular con-
ductionintheischemicconditionsdevelopedaftersubarach-
noid hemorrhage.
Pioneering studies by Segal and Duling [78, 79]s p a r k e d
interest in CVR as a mechanism for coordinating vasomotor
responses. A simple experimental paradigm, used by these
investigators to investigate vascular conduction in peripheral
vessels, is to follow the longitudinal spread of vasomotor
responses in arterioles to discrete stimulation of arterioles.
Thus, restricted application of vasoactive substances to
arteriolarsegmentsinducesbothdirecteﬀectsandsecondary
conducted vasomotor responses [78, 79]. The conducted
dilation response could not be explained by simple diﬀusion
or by neural innervation and is independent of blood ﬂow
and pressure, because occlusion of an arteriole to create a
sealed sac did not aﬀect the propagated dilation. Thus, the
pathway of signal conduction is located exclusively in vessel
wall components (endothelium and/or smooth muscle).
Cx40 and Cx43 have been identiﬁed in smooth muscle
and endothelium, whereas Cx45 has only been reported in
smooth muscle [80, 81]. Because connexins have electrical
and conductive properties that are diﬀerent from one an-
other [81, 82], selective upregulation and downregulation of
diﬀerent connexins, that is, the change in expression proﬁle,
likely shapes the change in vasomotor conductivity after an
ischemic insult.
Initial studies showed that the longitudinal spread of
arteriolar response to focal agonist application resembled
electrical decay along a cable [79], suggesting that electrical
signals travel by passive spread of current between cells in the
vessel wall. This electrotonic current travel therefore should
vary with transmembrane and axial resistances. However,
in vivo observations of conducted vasodilation indicate that
some vasomotor responses exhibit little decay [83, 84].
For example, hyperpolarization induced by acetylcholine in
arteriolar networks of the hamster cheek pouch in vivo was
maintained, and even grew, as it traveled [84]. The mecha-
nism for generating the additional current to aid the spread
ofhyperpolarizationmayinvolveinwardrectiﬁerK+channels
[85, 86] and/or Na+/K+ ATPase in smooth muscle cells
[87]. In cerebral penetrating arterioles, barium chloride
(BaCl2) attenuated both conducted dilation and constriction
responses to K+, suggesting that Kir may be involved in CVR
in the cerebrovasculature as well [88].6 International Journal of Vascular Medicine
8. Conclusion
The regulation of blood ﬂow in the brain is exceedingly com-
plex and only beginning to be elucidated. We have attempted
to broadly outline the major categories of mechanisms dis-
coveredsofar,focusingonpressureautoregulation,metabol-
ic regulation, and neurogenic regulation. Central to all three
groups is the neurovascular unit, composed of endothelial
cells, neurons, and astrocytes. The role of this substrate in a
variety of pathologic states characterized in part by failure of
cerebral blood ﬂow control (stroke, traumatic brain injury,
hypertension, Alzheimer’s disease) is the target of intense
investigationandunderscorestheneedtoexplorethecontrol
of blood ﬂow at level of the microcirculation as well.
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